Vectors Research Management, LLC Merck & Co., Inc. Transaction History

Vectors Research Management, LLC

$293 Million
Q4 2024

A detailed history of Vectors Research Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vectors Research Management, LLC holds 14,423 shares of MRK stock, worth $1.29 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

14,423

Previous 15,958 9.62%

Holding current value

$1.29 Million

Previous $1.81 Million 20.9%

% of portfolio

0.49%

Previous 0.55%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$96.31 - $114.76 $147,835 - $176,156	-1,535 Reduced 9.62%	14,423 $1.43 Million
Q3 2024 Nov 06, 2024	SELL	$111.15 - $128.97 $42,792 - $49,653	-385 Reduced 2.36%	15,958 $1.81 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $61,776 - $66,347	-499 Reduced 2.96%	16,343 $2.02 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $123,431 - $143,825	-1,090 Reduced 6.08%	16,842 $2.22 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $31,556 - $34,341	-315 Reduced 1.73%	17,932 $1.96 Million
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $29,443 - $32,698	286 Added 1.59%	18,247 $1.75 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $112,519 - $122,641	-1,036 Reduced 5.45%	17,961 $2.07 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $21,926 - $24,465	-213 Reduced 1.11%	18,997 $2.02 Million
Q4 2022 Feb 08, 2023	BUY	$87.44 - $112.11 $85,866 - $110,092	982 Added 5.39%	19,210 $2.13 Million
Q3 2022 Nov 08, 2022	SELL	$84.53 - $94.96 $34,657 - $38,933	-410 Reduced 2.2%	18,228 $1.57 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $34,648 - $39,275	-415 Reduced 2.18%	18,638 $1.7 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $22,126 - $24,802	301 Added 1.61%	19,053 $1.56 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $59,847 - $74,967	828 Added 4.62%	18,752 $1.44 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $69,386 - $76,307	968 Added 5.71%	17,924 $1.35 Million
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $29,952 - $33,130	426 Added 2.58%	16,956 $1.32 Million
Q1 2021 May 18, 2021	SELL	$68.86 - $81.11 $4,682 - $5,515	-68 Reduced 0.41%	16,530 $1.27 Million
Q4 2020 Feb 09, 2021	BUY	$71.77 - $79.65 $488,466 - $542,097	6,806 Added 69.51%	16,598 $1.36 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $5,854 - $6,636	-80 Reduced 0.81%	9,792 $815,000
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $492,728 - $560,669	6,997 Added 243.37%	9,872 $763,000
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $698 - $787	-9 Reduced 0.31%	2,875 $261,000
Q3 2019 Nov 15, 2019	SELL	$76.08 - $82.93 $1,825 - $1,990	-24 Reduced 0.83%	2,884 $243,000
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $69 - $81	1 Added 0.03%	2,908 $244,000
Q1 2019 Jul 15, 2019	BUY	$69.58 - $79.36 $163,582 - $186,575	2,351 Added 422.84%	2,907 $242,000
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $132,045 - $153,237	-2,024 Reduced 78.45%	556 $43,000
Q3 2018 Nov 15, 2018	BUY	$57.69 - $67.84 $148,840 - $175,027	2,580 New	2,580 $156,000

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.

Account

Vectors Research Management, LLC Merck & Co., Inc. Transaction History